RESPONSE TO PHYTOHÆMAGGLUTININ AND POKEWEED MITOGEN IN CHRONIC LYMPHOCYTIC LEUKÆMIA

Daniel Catovsky(Institute of Cancer Research), P Stavem, A. V. Hoffbrand(London Postgraduate Medical and Dental Education), G. Brittinger(Ruhrlandklinik), E König(Ruhrlandklinik), E. Tripp(London Postgraduate Medical and Dental Education), G. Cohnen(Ruhrlandklinik), S S Frøland(Oslo University Hospital), Steven D. Douglas(Purdue University West Lafayette)
The Lancet
April 1, 1972
10.1016/s0140-6736(72)90549-1
Cited by 42

Related Papers

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
|Blood|2008|3.2k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial
|The Lancet|2007|679
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488